MedPath

Lateral Neck Lymph Node Mapping in Thyroid Cancer

Not Applicable
Conditions
Thyroid Cancer
Interventions
Procedure: Modified lateral neck lymph node dissection
Procedure: Lateral neck sentinel lymph node biopsy
Procedure: Super selective lateral neck lymph node dissection
Registration Number
NCT04312087
Lead Sponsor
Fudan University
Brief Summary

This study includes papillary thyroid cancer patients who have unpalpable lateral neck lymph nodes but suspicious on ultrasound and/or CT. Carbon nanoparticles is used as the tracer for lateral neck lymph node mapping.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Newly diagnosed papillary thyroid cancer
  • The maximum diameter of the thyroid cancer <3 cm with enough normal thyroid tissue for tracer injection
  • Unpalpable lateral neck lymph nodes
  • Ultrasound and CT showed suspected lateral neck lymph nodes <2 cm
Read More
Exclusion Criteria
  • Previously treated thyroid cancer
  • High risk thyroid cancer (e.g. with severe extra-adenial invasion or extensive lymph node metastasis or poorly differentiated thyroid cancer)
  • Patients with distant metastasis
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MLNDModified lateral neck lymph node dissectionModified lateral neck dissection (compartment II-V) is performed in all patients.
SLNBModified lateral neck lymph node dissectionSentinel lymph node biopsy in the lateral neck is performed. The decision of neck dissection is based on the result of sentinel lymph node biopsy.
SLNBLateral neck sentinel lymph node biopsySentinel lymph node biopsy in the lateral neck is performed. The decision of neck dissection is based on the result of sentinel lymph node biopsy.
SLNBSuper selective lateral neck lymph node dissectionSentinel lymph node biopsy in the lateral neck is performed. The decision of neck dissection is based on the result of sentinel lymph node biopsy.
Primary Outcome Measures
NameTimeMethod
Lymph node counts1 month after surgery

Dyed versus undyed lymph node counts in lateral neck compartments

Secondary Outcome Measures
NameTimeMethod
Lymph node metastasis rate1 month after surgery

The rate of lymph node metastasis in lateral neck compartments

Trial Locations

Locations (1)

Fudan University Shanghai Cancer Center

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath